Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine

Simple item page
dc.contributor.authorVan Regenmortel MHV
dc.date.accessioned2013-07-03T08:19:42Z
dc.date.available2013-07-03T08:19:42Z
dc.date.issued2012
dc.descriptionAlgemeen
dc.descriptionStellenbosse Instituut vir Gevorderde Navorsing (SIGNA)
dc.descriptionPlease help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
dc.identifier.citationArchives of Virology
dc.identifier.urihttp://hdl.handle.net/10019.1/82578
dc.publisherSPRINGER WIEN, SACHSENPLATZ 4-6, PO BOX 89, VIENNA, AUSTRIA, A-1201
dc.titleRequirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine
dc.typeJournal Articles (subsidised)
Files
Collections
2012 - Research Outputs